QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 calidi-biotherapeutics-stock-jumps-39-after-hours--whats-going-on

Calidi Biotherapeutics (NYSE: CLDI) surged 39.47% after hours Tuesday, following renewed investor interest in its innovative ca...

 mustang-bio-mbio-stock-explodes-260-after-fda-grants-key-cancer-drug-designation

Mustang Bio shares are trading sharply higher Monday afternoon. The FDA granted Orphan Drug Designation to its cell therapy, MB...

 why-greenbrier-shares-are-trading-higher-by-over-13-here-are-20-stocks-moving-premarket

Shares of The Greenbrier Companies, Inc. (NYSE: GBX) rose sharply in today's pre-market trading after the company posted st...

 mustang-bio-receives-fda-orphan-drug-designation-for-mb-101-treatment-of-malignant-glioma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425

 mustang-bio-designated-orphan-designation-status-for-an-autologous-ex-vivo-expanded-cluster-of-differentiation-62-enriched-naive-and-memory-t-cell-investigational-product-that-has-been-genetically-modified-using-a-self-inactivating-lentiviral-vector-to-express-an-il13ralpha2-targeted-hinge-optimized-4-1bb-costimulatory-chimeric-antigen-receptor-with-a-truncated-cd19-for-the-treatment-of-malignant-glioma

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=1082425

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION